Skip to main content
. 2018 Apr 30;8:133. doi: 10.3389/fonc.2018.00133

Figure 4.

Figure 4

The crucial role of transforming growth factor-βs (TGF-βs) in osteosarcoma tumor growth and metastatic dissemination. Following bone degradation, the TGF-βs trapped in the bone matrix are released and promote osteosarcoma growth and metastatic dissemination by targeting both osteosarcoma tumor cells and their microenvironment. TGF-βs target osteosarcoma cells: TGF-βs stimulate “epithelial–mesenchymal transition-like” (EMT), cell migration, and invasion in part by increasing matrix metalloproteinase-2 (MMP-2) expression. TGF-βs target tumor microenvironment: TGF-βs upregulate the expression of osteolytic factors such as receptor activator of nuclear factor kappa-B ligand (RANKL) and interleukin-11 (IL-11) and therefore stimulate bone osteolysis and the secretion of protumoral factors. TGF-βs upregulate platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) expression, and therefore angiogenesis. Finally, TGF-βs exert immunosuppressive effects by regulating immune cell proliferation and activity.